Immune response to Mycobacterium tuberculosis infection in the parietal pleura of patients with tuberculous pleurisy

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Caramori, Gaetano ^a   Lasagna, Lisa ^b   Casalini, Angelo G ^c   Adcock, Ian M ^d   Casolari, Paolo ^a   Contoli, Marco ^a   Tafuro, Federica ^b   Padovani, Anna ^a   Chung, Kian Fan ^d   Barnes, Peter J ^d   Papi, Alberto ^a   Rindi, Guido ^e   Bertorelli, Giuseppina ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c Parma Hospital   (Italy)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; LEUKOCYTE ELASTASE; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOID RELATED ORPHAN RECEPTOR GAMMA 2; STAT4 PROTEIN; STAT6 PROTEIN; TOLONIUM CHLORIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CRTH2; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRYPTASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; RORC PROTEIN, HUMAN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPHOCYTE COUNT; MALE; PARIETAL PLEURA; PLEURA; PLEURISY; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; REGULATORY T LYMPHOCYTE; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; TUBERCULOSIS; TUBERCULOUS PLEURISY; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; EOSINOPHIL; GENETICS; GRANULOCYTE; HELPER CELL; IMMUNOLOGY; MAST CELL; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PATHOLOGY; PLEURA EFFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MYCOBACTERIUM TUBERCULOSIS;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EOSINOPHILS; FEMALE; GRANULOCYTES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON-GAMMA; MALE; MAST CELLS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; PLEURA; PLEURAL EFFUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TUBERCULOSIS; TUBERCULOSIS, PLEURAL;

EID: 79960854388     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022637     Document Type: Article

References (41)

1. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC, (2005) Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293: 2767-2775.
2. Pèrez-Rodriguez E, Light RW, (2008) Effusions from infections: tuberculosis. In: Light RW, Lee YCG, editors. Textbook of pleural diseases. 2nd ed London, MA Hodder Arnold pp. 367-378.
3. Baumann MH, Nolan R, Petrini M, Lee YC, Light RW, et al. (2007) Pleural tuberculosis in the United States. Chest 131: 1125-1132.
4. Gopi A, Madhavan SM, Sharma SK, Sahn SA, (2007) Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 131: 880-889.
5. Capelozzi VL, Saldiva PH, Antonangelo L, De Carvalho TS, Logulo A, et al. (1997) Quantitation in inflammatory pleural disease to distinguish tuberculous and paramalignant from chronic non-specific pleuritis. J Clin Pathol 50: 935-940.
6. Rossi GA, Balbi B, Manca F, (1987) Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. Am Rev Respir Dis 136: 575-579.
7. Mitra DK, Sharma SK, Dinda AK, Bindra MS, Madan B, et al. (2005) Polarized helper T cells in tubercular pleural effusion: phenotypic identity and selective recruitment. Eur J Immunol 35: 2367-2375.
8. Okamoto M, Hasegawa Y, Hara T, Hashimoto N, Imaizumi K, et al. (2005) T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest 128: 4030-4035.
9. Sharma SK, Mitra DK, Balamurugan A, Pandey RM, Mehra NK, (2002) Cytokine polarization in miliary and pleural tuberculosis. J Clin Immunol 22: 345-352.
10. Guyot-Revol V, Innes JA, Hackfort S, Hinks T, Lalvani A, (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
11. Sharma PK, Saha PK, Singh A, SK Sharma SK, Ghosh B, et al. (2009) FOXP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med 179: 1061-1070.
12. Marchant A, Amedei A, Azzurri A, Vekemans J, Benagiano M, et al. (2001) Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. Am J Respir Cell Mol Biol 24: 187-194.
13. Jalapathy KV, Prabha C, Das SD, (2004) Correlates of protective immune response in tuberculous pleuritis. FEMS Immunol Med Microbiol 40: 139-145.
14. Okamoto M, Imaizumi K, Hasegawa Y, Hashimoto N, Sumida A, et al. (2007) Macrophage-derived chemokine in malignant and tuberculous pleural effusions. Respirology 12: 581-584.
15. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, et al. (2006) Littman. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
16. Khader SA, Cooper AM, (2008) IL-23 and IL-17 in tuberculosis. Cytokine 41: 79-83.
17. Sugawara I, Yamada H, Mizuno S, (2003) Relative importance of STAT4 in murine tuberculosis. J Med Microbiol 52: 29-34.
18. Qiu L, Huang D, Chen CY, Wang R, Shen L, et al. (2008) Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses. J Infect Dis 198: 1514-1519.
19. Cosmi L, Annunziato F, Maggi E, Romagnani S, Manetti R, (2001) Chemoattractant receptors expressed on type 2 T cells and their role in disease. Int Arch Allergy Immunol 125: 273-279.
20. Sundrud MS, Grill SM, Ni D, Nagata K, Alkan SS, et al. (2003) Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation. J Immunol 171: 3542-549.
21. Singh SP, Zhang HH, Foley JF, Hedrick MN, Farber JM, (2008) Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 180: 214-221.
22. Curtis MM, Way SS, (2009) Interleukin-17 in host defense against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185.
23. Pokkali S, Das SD, (2008) Expression of CXC and CC type of chemokines and its receptors in tuberculous and non-tuberculous effusions. Cytokine 41: 3073-14.
24. Santucci MB, Bocchino M, Garg SK, Marruchella A, Colizzi V, et al. (2004) Expansion of CCR5+ CD4+ T-lymphocytes in the course of active pulmonary tuberculosis. Eur Respir J 24: 638-643.
25. Lin PL, Pawar S, Myers A, Pegu A, Fuhrman C, et al. (2006) Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 74: 3790-3803.
26. Saukkonen JJ, Bazydlo B, Thomas M, Strieter RM, Keane J, et al. (2002) Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun 70: 1684-1693.
27. Chen X, Zhou B, Li M, Deng Q, Wu X, et al. (2007) CD4(+)CD25(+)FOXP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123: 50-59.
28. Muñoz S, Hernández-Pando R, Abraham SN, Encison JA, (2003) Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol 170: 5590-5596.
29. Taweevisit M, Poumsuk U, (2007) High mast cell density associated with granulomatous formation in tuberculous lymphadenitis. Southeast Asian J Trop Med Public Health 38: 115-119.
30. Carlos D, Frantz FG, Souza Júnior DA, Jamur MC, Oliver C, et al. (2009) TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection. Microbes Infect 11: 770-778.
31. Andersson CK, Mori M, Bjermer L, Löfdahl CG, Erjefält JS, (2009) Novel site-specific mast cell subpopulations in the human lung. Thorax 64: 297-305.
32. Muñoz S, Rivas-Santiago B, Enciso JA, (2009) Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains. Scand J Immunol 70: 256-263.
33. Taghon T, Yui MA, Rothenberg EV, (2007) Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3. Nat Immunol 8: 845-855.
34. Stern JN, Keskin DB, Romero V, Zuniga J, Encinales L, et al. (2009) Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol Res 45: 1-12.
35. Nakamura Y, Ghaffar O, Olivenstein R, Taha RA, Soussi-Gounni A, et al. (1999) Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 103: 215-222.
36. Boutin C, Astoul P, (1998) Diagnostic thoracoscopy. Clin Chest Med 19: 295-309.
37. Mori PA, Casalini AG, Melioli A, (2006) Toracoscopia medica: metodica e complicanze. In: Casalini AG, editors. Pneumologia Interventistica MA Springer-Verlag Italia pp. 461-72.
38. Cook SM, Bartos RE, Pierson CL, Frank TS, (1994) Detection and characterization of atypical mycobacteria by the polymerase chain reaction. Diagn Mol Pathol 3: 53-8.
39. Varani K, Caramori G, Vincenzi F, Adcock I, Casolari P, et al. (2006) Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care 173: 398-406.
40. Pesci A, Foresi A, Bertorelli G, Chetta A, Olivieri D, (1993) Histochemical characteristics and degranulation of mast cells in epithelium and lamina propria of bronchial biopsies from asthmatic and normal subjects. Am Rev Respir Dis 147: 684-9.
41. Di Stefano A, Caramori G, Gnemmi I, Contoli M, Vicari C, et al. (2009) Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients. Clin Exp Immunol 157: 316-24.